IFRS Consolidated financial statements Q3.2025 24 October, 2025 by Phạm Long 1. Consolidated Financial Statement Q2.2023 2. Separated Financial Statement Q2.2023 3. IFRS Financial Statement Q2.2023
Explanation on profit differences compared to the same period Q3.2025 24 October, 2025 by Phạm Long 1. Consolidated Financial Statement Q2.2023 2. Separated Financial Statement Q2.2023 3. IFRS Financial Statement Q2.2023
Q3.2025 Separate financial statements 24 October, 2025 by Phạm Long 1. Consolidated Financial Statement Q2.2023 2. Separated Financial Statement Q2.2023 3. IFRS Financial Statement Q2.2023
Q3.2025 Consolidated financial statements 24 October, 2025 by Phạm Long 1. Consolidated Financial Statement Q2.2023 2. Separated Financial Statement Q2.2023 3. IFRS Financial Statement Q2.2023
Audited consolidated semi-annual financial statements 2025 30 August, 202529 August, 2025 by Phạm Long 1. Consolidated Financial Statement Q2.2023 2. Separated Financial Statement Q2.2023 3. IFRS Financial Statement Q2.2023
Audited separate semi-annual financial statements 2025 30 August, 202529 August, 2025 by Phạm Long 1. Consolidated Financial Statement Q2.2023 2. Separated Financial Statement Q2.2023 3. IFRS Financial Statement Q2.2023
Explanation for y-o-y profit difference semi-annual 2025 30 August, 202529 August, 2025 by Phạm Long 1. Consolidated Financial Statement Q2.2023 2. Separated Financial Statement Q2.2023 3. IFRS Financial Statement Q2.2023
Explanation on profit difference of VAS financial statements Q2.2025 25 July, 2025 by Phạm Long 1. Consolidated Financial Statement Q2.2023 2. Separated Financial Statement Q2.2023 3. IFRS Financial Statement Q2.2023
Consolidated financial statements Q2.2025 25 July, 2025 by Phạm Long 1. Consolidated Financial Statement Q2.2023 2. Separated Financial Statement Q2.2023 3. IFRS Financial Statement Q2.2023
Separate financial statements Q2.2025 25 July, 2025 by Phạm Long 1. Consolidated Financial Statement Q2.2023 2. Separated Financial Statement Q2.2023 3. IFRS Financial Statement Q2.2023